The following are commonly asked questions and their answers about what happens after submitting a grant application and who to contact before and after the scientific review of the application.
Who do I contact after submitting my application?
In general, you do not need to contact NIAMS after submitting your application. If we need any further information or material, NIAMS will contact you.
However, if you must contact NIAMS, the appropriate personnel to contact are:
- BEFORE REVIEW of your application — the Scientific Review Officer (SRO) identified in your eRA Commons account.
- AFTER REVIEW — the Program Officer (or Program Director) identified on the front of your summary statement and in your eRA Commons account.
Who do I contact before review?
From the time your application has been submitted until the time of the review meeting, all correspondence about your application should be directed to the Scientific Review Officer (SRO) identified in your eRA Commons account.
Who do I contact after review?
After the review meeting, all correspondence about your application should be directed to the Program Officer identified on the front of your summary statement and in your eRA Commons account.
How do I identify a study section where my grant should be reviewed (self-referral)?
Find a list of Study Sections at the Center for Scientific Review (CSR).
What happens to my research project grant (R01/R03/R21) application after it is received for peer review?
See our Peer Review Process Overview.
Will my application be reviewed by a CSR Study Section or a NIAMS Study Section?
The Center for Scientific Review (CSR) manages the initial review groups that review most of the investigator-initiated applications. NIAMS manages the review of applications submitted in response to special solicitations and for unique programs, including applications responding to requests for applications (RFAs) or requests for proposals (RFPs), applications responding to some program announcements with set-aside funds, applications for cooperative agreements and research center grants, and certain investigator-initiated applications (e.g., training grants, career development awards, and clinical trials applications).